LAUSR

1 Moe N, Stenseng IH, Krostad S et al. The burden of human metapneumovirus and respiratory syncytial virus infection in hospitalized Norwegian children. J. Infect. Dis. 2017; 216: 110–6. 2 Kapelushnik J, Engelhard D, Mehta J et al. Sequential respiratory syncytial virus and cytomegalovirus pneumonia following bone marrow transplantation. J. Med. Virol. 1995; 46: 169–71. 3 Lam TM, Le BL, Wen CH et al. Comprehensive analyses and characterization of haemophagocytic lymphohistiocytosis in Vietnamese children. Br. J. Haematol. 2010; 148: 301–10. 4 Kumar B, Aleem S, Saleh H, Petts J, Ballas ZK. A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults. J. Clin. Immunol. 2017; 37: 638–43. 5 Mizushima Y, Hamano T, Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann. Rheum. Dis. 1982; 41: 263–7. 6 Wakiguchi H, Ohga S. Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation. Nihon Rinsho Meneki Gakkai Kaishi 2016; 39: 190–6. 7 Otsubo K, Fukumura A, Hirayama M, Morimoto T, Kato M, Mochizuki H. Hemophagocytic lymphohistiocytosis caused by systemic herpes simplex virus type 1 infection: Successful treatment with dexamethasone palmitate. Pediatr. Int. 2016; 58: 390–3.